Our study evaluated growth as a clinical outcome measure of peritoneal dialysis (PD) adequacy in children with end-stage renal disease (ESRD).
♦ Design
This retrospective single-center study was carried out in our tertiary-care medical center.
♦ Patients
The study enrolled 24 patients who initiated dialysis after January 1, 1995, and who had been on dialysis for a minimum of 1 year.
♦ Results
The weekly mean total [PD + residual renal function (RRF)] creatinine clearance (CCr) and Kt/Vurea were 70.3 ± 18 L per 1.73 m2 and 3.45 ± 0.73, respectively. Of the 24 patients, 12 (50%) were anuric. The mean height standard deviation score (SDS) changed to –1.78 at the end of 1 year from –1.58 at baseline. Catch-up growth (positive Δ height SDS) was observed in 9 patients (37%), 7 of whom (78%) had residual renal function (RRF). In contrast, only 5 of 15 patients (33%) with a negative ΔSDS for height had RRF (p < 0.025). The mean height SDS in patients with RRF improved to –1.64 from –1.78; in patients without RRF, it worsened to –1.90 from –1.37 (p = 0.01). While the weekly total Kt/Vurea in patients with RRF (3.53) was similar to that in patients without RRF (3.37, p = 0.6), only the native Kt/Vurea had a significant (but weak) positive correlation with Δheight SDS (r2 = 0.17, p = 0.04). In contrast, the total weekly CCr was significantly higher (p = 0.001) in patients with RRF (81.1 L/1.73 m2) as compared with those without RRF (59.5 L/1.73 m2). However, only the native CCr—and not the dialysis CCr—had a significant (but weak) positive correlation with Δheight SDS (r2 = 0.17, p = 0.04).
♦ Conclusions
These preliminary data provide evidence for a correlation between solute clearance and growth, with RRF exerting a significant influence on that outcome. The Kt/Vurea data also appear to contradict the presumed equivalence of PD and native clearance in children with ESRD.
WaradyB.A., AlexanderS.R., WatkinsS., KohautE., HarmonW.E.Optimal care of the pediatric end-stage renal disease patient on dialysis.Am J Kidney Dis1999; 33: 567–83.
2.
National Kidney Foundation.NKF–K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2000.Am J Kidney Dis2001; 37(Suppl 1): S65–136.
3.
ChadhaV., WaradyB.A.What are the clinical correlates of adequate peritoneal dialysis?Semin Nephrol2001; 21: 480–9.
4.
BurkartJ.M.Adequacy of peritoneal dialysis.Adv Ren Replace Ther2000; 7: 310–23.
5.
BrandesJ.C., PieringW.F., BeresJ.A., BlumenthalS.S., FritscheC.Clinical outcome of continuous ambulatory peritoneal dialysis predicted by urea and creatinine kinetics.J Am Soc Nephrol1992; 2: 1430–5.
6.
GenestierS., HedelinG., SchafferP., FallerB.Prognostic factors in CAPD patients: a retrospective study of a 10-year period.Nephrol Dial Transplant1995; 10: 1905–11.
7.
ChurchillD.N., TaylorD.W., KeshaviahP.R., and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
8.
DaviesS.J., PhillipsL., GriffithsA.M., NaishP.F., RussellG.I.Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients.Kidney Int2000; 57: 1743–54.
9.
MakS.K., WongP.N., LoK.Y., TongG.M.W., FungL.H., WongA.K.M.Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis2000; 36: 105–14.
10.
DaviesS.J., PhillipsL., RussellG.I.Peritoneal solute transport predicts survival on CAPD independently of residual renal function.Nephrol Dial Transplant1998; 13: 962–8.
11.
WangT., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.Increased peritoneal permeability is associated with decreased fluid and small solute removal and higher mortality in CAPD patients.Nephrol Dial Transplant1998; 13: 1242–9.
12.
ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.R., OreopoulosD.G., PagéD.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. the Canada–U.S.A. (CANUSA) Peritoneal Dialysis Study Group.J Am Soc Nephrol1998; 9: 1285–92.
13.
MellitsE.D., CheekD.B.The assessment of body water and fatness from infancy to adulthood.Monogr Soc Res Child Dev1970; 35: 12–26.
14.
WaradyB.A.The use of the peritoneal equilibration test to modify peritoneal dialysis modality in children.Semin Dial1994; 7: 403–8.
15.
HolttaT., RonnholmK., JalankoH., HolmbergC.Clinical outcome of pediatric patients on peritoneal dialysis under adequacy control.Pediatr Nephrol2000; 14: 889–97.
16.
McCauleyL., ChampouxS., ParvexP., RoddC., SharmaA., TomA.Enhanced growth in children on peritoneal dialysis (PD): dialysis dose, nutrition, and metabolic control (Abstract).Perit Dial Int2000; 20(Suppl 1): S89.
17.
SchaeferF., KlausG., MehlsO.Peritoneal transport properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dialysis. Mid-European Pediatric Peritoneal Dialysis Study Group.J Am Soc Nephrol1999; 10: 1786–92.
18.
GulatiS., StephensD., BalfeJ.A., SeckerD., HarveyE., BalfeJ.W.Children with hypoalbuminemia on continuous peritoneal dialysis are at risk for technique failure.Kidney Int2001; 59: 2361–7.
19.
WongC.S., HingoraniS., GillenD.L., SherrardD.J., WatkinsS.L., BallA.M.Hypoalbuminemia and risk of death in the U.S. pediatric ESRD population (Abstract).J Am Soc Nephrol2000; 11: 171A.
